Dr. Mark Socinski from the University of Pittsburgh reviews
evidence to support doublet chemo over single agent for marginal
performance status (PS2) patients with advanced NSCLC.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.